Michelle Raley Drug Delivery Leader Articles
-
Advancing Multi-Pathology Disease-Modifying Therapy For Neurodegenerative Diseases
10/6/2026
We discuss Amyl’s approach to developing therapeutics designed to target multiple amyloid fibrils and the use of brain shuttle technology to enhance delivery across the blood-brain barrier.